GLOBAL TUBERCULOSIS REPORT, 2017
5th Dec, 2017
Global Tuberculosis Report, 2017 for GS Mains
The purpose of WHO's Global Tuberculosis Report
is to provide a comprehensive and up-to-date assessment of the TB epidemic and of progress in care and prevention at global, regional and country levels.
TB is the ninth leading cause of death worldwide and the leading cause from a single infectious agent, ranking above HIV/AIDS. In 2016, there were an estimated 1.3 million TB deaths among HIV-negative people (down from 1.7 million in 2000) and an additional 374 000 deaths among HIV-positive people. An estimated 10.4 million people fell ill with TB in 2016: 90% were adults, 65% were male, 10% were people living with HIV (74% in Africa) and 56% were in five countries: India, Indonesia, China, the Philippines and Pakistan.
Most deaths from TB could be prevented with early diagnosis and appropriate treatment. Millions of people are diagnosed and successfully treated for TB each year, averting millions of deaths (53 million 2000-2016), but there are still large gaps in detection and treatment.
Specific targets set in the End TB Strategy include a 90% reduction in TB deaths and an 80% reduction in TB incidence (new cases per year) by 2030, compared with 2015. Achieving these targets requires provision of TB care and prevention within the broader context of universal health coverage, multisectoral action to address the social and economic determinants and consequences of TB, and technological breakthroughs by 2025 so that incidence can fall faster than rates achieved historically.
Hereby providing the gist of the report and status of India.
2. Zoonotic TB
3. Drug-resistant TB
4. About report
5. The End of TB strategy
6. Outcome of the report
7. The WHO Global Task Force on TB Impact Measurement
8. Persistent gaps in care and financing
9. Way forward